Skip to main content

American Thoracic Society

Events
Search
Sign Up
Sign In

Item Added to Cart

You just added

You have item(s) in your cart

  • Proceed to Checkout

A Brief Review of Clinical and Real-World Evidence for Using a Biologic to Treat Severe Eosinophilic Asthma

  • Overview

Thank you

Thank you for joining us today. Industry Innovations Webinars are archived on the ATS YouTube channel under the Industry Innovation playlist.

Expect a brief satisfaction survey via email. Your feedback is appreciated as it helps improve programming for the future.

Description

This expert-led event will include a review and discussion of clinical and real-world data evaluating a biologic treatment to help reduce exacerbations and maintenance OCS use, as well as long-term clinical efficacy and safety data associated with the product.

Sponsored by GSK.

By registering for this webinar, you agree your information will be shared with the sponsor.

No CME or MOC credits are available for this program.

Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.

Contributors

  • Maeve O’Connor, MD

    Allergy, Asthma & Immunology Relief
    Charlotte, NC
    Principal Investigator
    Allergy, Asthma & Immunology Research Institute

October 6, 2020
Tue 6:30 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
support@blueskyelearn.com
+1 (858) 201-4136
Register
Log In
  • New
  • Existing

Forgot password?
  • Events
  • Search
  • Support
  • Sign Up
  • Sign In
  • Privacy Policy | Cookies Policy